Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 June 2007, Vol. 109, No. 12, pp. 5168-5177.
Prepublished online as a Blood First Edition Paper on March 12, 2007; DOI 10.1182/blood-2006-06-029173.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-06-029173v1
109/12/5168    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C.
Right arrow Articles by Morgan, R. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C.
Right arrow Articles by Morgan, R. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 15, 2006
Accepted February 24, 2007

Cytokine independent growth and clonal expansion of a primary human CD8+ T cell clone following retroviral transduction with the IL-15 gene

Cary Hsu, Stephanie A Jones, Cyrille J Cohen, Zhili Zheng, Keith Kerstann, Juhua Zhou, Paul F Robbins, Peter D Peng, Xinglei Shen, Theotonius J Gomes, Cynthia E Dunbar, David J Munroe, Claudia Stewart, Kenneth Cornetta, Danny Wangsa, Thomas Ried, Steven A Rosenberg, and Richard A Morgan*

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD
Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
Laboratory of Molecular Technology, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN
Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

* Corresponding author; email: morgan{at}mail.nih.gov.

Malignancies arising from retrovirally transduced hematopoietic stem cells have been reported in animal models and human gene therapy trials. Whether mature lymphocytes are susceptible to insertional mutagenesis is unknown. We have characterized a primary human CD8+ T cell clone which exhibited logarithmic ex-vivo growth in the absence of exogenous cytokine support for greater than 1 year after transduction with a MLV-based vector encoding the T cell growth factor IL-15. Phenotypically, the clone was CD28-, CD45RA-, CD45RO+, and CD62L-, a profile consistent with effector memory T lymphocytes. After gene transfer with tumor antigen-specific T cell receptors, the clone secreted IFN-{gamma} upon encountering tumor targets, providing further evidence that they derived from mature lymphocytes. Gene expression analyses revealed no evidence of insertional activation of genes flanking the retroviral insertion sites. The clone exhibited constitutive telomerase activity, and the presence of autocrine loop was suggested by impaired cell proliferation following knockdown of the IL-15R{alpha}. The generation of this cell line suggests that non-physiological expression of IL-15 can result in the long-term in vitro growth of mature human T lymphocytes. The cytokine-independent growth of this line was a rare event that has not been observed in other IL-15 vector transductions experiments or with any other integrating vector system. It does not appear that the retroviral vector integration sites played a role in the continuous growth of this cell clone, but this remains under investigation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
C. U. Louis, K. Straathof, C. M. Bollard, C. Gerken, M. H. Huls, M. V. Gresik, M.-F. Wu, H. L. Weiss, A. P. Gee, M. K. Brenner, et al.
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients
Blood, March 12, 2009; 113(11): 2442 - 2450.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Boni, P. Muranski, L. Cassard, C. Wrzesinski, C. M. Paulos, D. C. Palmer, L. Gattinoni, C. S. Hinrichs, C.-C. Chan, S. A. Rosenberg, et al.
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers
Blood, December 1, 2008; 112(12): 4746 - 4754.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Zhang, M. V. Shah, J. Yang, S. B. Nyland, X. Liu, J. K. Yun, R. Albert, and T. P. Loughran Jr.
Network model of survival signaling in large granular lymphocyte leukemia
PNAS, October 21, 2008; 105(42): 16308 - 16313.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Quintarelli, J. F. Vera, B. Savoldo, G. M. P. Giordano Attianese, M. Pule, A. E. Foster, H. E. Heslop, C. M. Rooney, M. K. Brenner, and G. Dotti
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes
Blood, October 15, 2007; 110(8): 2793 - 2802.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020